This trial is testing a new drug for people with melanoma that has spread or can't be removed surgically, and who have already tried a different kind of treatment.
3 Primary · 10 Secondary · Reporting Duration: From screening until death (approx. up to 2 years)
195 Total Participants · 4 Treatment Groups
Primary Treatment: Ceralasertib · No Placebo Group · Phase 2
Age 18+ · All Participants · 7 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: